Nosocomial Gram-negative bacteremia in intensive care: Epidemiology, antimicrobial susceptibilities, and outcomes

International Journal of Infectious Diseases

Volumn 37, Issue , 2015, Pages 129-134

  Sligl, Wendy Irene ^a   Dragan, Tatiana ^a   Smith, Stephanie Wrenn ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antimicrobial resistance; Bacteremia; Critical care; Gram negative; Intensive care; Nosocomial infection

Indexed keywords

AMIKACIN; AZTREONAM; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPTIC SHOCK; ADOLESCENT; AGED; ANTIBIOTIC RESISTANCE; BACTEREMIA; CROSS INFECTION; GRAM-NEGATIVE BACTERIAL INFECTIONS; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL CARE; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938060715     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.06.024     Document Type: Article

References (40)

1. Colpan A., Akinci E., Erbay A., Balaban N., Bodur H. Evaluation of risk factors for mortality in intensive care units: a prospective study from a referral hospital in Turkey. Am J Infect Control 2005, 33:42-47.
2. Magill S.S., Edwards J.R., Bamberg W., Beldavs Z.G., Dumyati G., Kainer M.A., et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014, 370:1198-1208.
3. Pittet D., Li N., Woolson R.F., Wenzel R.P. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24:1068-1078.
4. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
5. Kollef M.H., Sherman G., Ward S., Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
6. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108-121.
7. Laupland K.B., Kirkpatrick A.W., Church D.L., Ross T., Gregson D.B. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 2004, 58:137-145.
8. Fridkin S.K., Welbel S.F., Weinstein R.A. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997, 11:479-496.
9. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000;28:429-48.
10. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
11. Karakoc C., Tekin R., Yesilbag Z., Cagatay A. Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci 2013, 17:951-957.
12. Sligl W., Taylor G., Brindley P.G. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006, 10:320-325.
13. Centers for Disease Control and Prevention (CfDCaP) document. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central line-associated Bloodstream Infection). 2015, 〈http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf〉.
14. Boncagni F., Francolini R., Nataloni S., Skrami E., Gesuita R., Donati A., et al. Epidemiology and clinical outcome of healthcare-associated infections: a 4-year experience of an Italian ICU. Minerva Anestesiol 2015, 81(7):765-775.
15. Wan Q., Ye Q., Su T., Zhou J. The epidemiology and distribution of pathogens and risk factors for mortality in liver transplant recipients with Gram negative bacteremia. Hepatogastroenterology 2014, 61:1730-1733.
16. Shi S.H., Kong H.S., Xu J., Zhang W.J., Jia C.K., Wang W.L., et al. Multidrug resistant Gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009, 11:405-412.
17. Meric M., Willke A., Caglayan C., Toker K. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn J Infect Dis 2005, 58:297-302.
18. Erbay H., Yalcin A.N., Serin S., Turgut H., Tomatir E., Cetin B., et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 2003, 29:1482-1488.
19. Ray G.T., Baxter R., DeLorenze G.N. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa. Clin Infect Dis 2005, 41:441-449.
20. Zervos M.J., Hershberger E., Nicolau D.P., Ritchie D.J., Blackner L.K., Coyle E.A., et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003, 37:1643-1648.
21. Pakyz A.L., Lee J.A., Ababneh M.A., Harpe S.E., Oinonen M.J., Polk R.E. Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals. J Antimicrob Chemother 2012, 67:1562-1564.
22. Porwal R., Gopalakrishnan R., Rajesh N.J., Ramasubramanian V. Carbapenem resistant Gram-negative bacteremia in an Indian intensive care unit: a review of the clinical profile and treatment outcome of 50 patients. Indian J Crit Care Med 2014, 18:750-753.
23. Routsi C., Pratikaki M., Platsouka E., Sotiropoulou C., Papas V., Pitsiolis T., et al. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive Care Med 2013, 39:1253-1261.
24. Voets G.M., Platteel T.N., Fluit A.C., Scharringa J., Schapendonk C.M., Stuart J.C., et al. Population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 2012, 7:e52102.
25. Seiffert S.N., Hilty M., Perreten V., Endimiani A. Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?. Drug Resist Updat 2013, 16:22-45.
26. Curcio D. Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge?. Curr Clin Pharmacol 2014, 9:27-38.
27. Shorr A.F., Micek S.T., Welch E.C., Doherty J.A., Reichley R.M., Kollef M.H. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 2011, 39:46-51.
28. Johnson M.T., Reichley R., Hoppe-Bauer J., Dunne W.M., Micek S., Kollef M. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011, 39:1859-1865.
29. Zahar J.R., Timsit J.F., Garrouste-Orgeas M., Francais A., Vesin A., Descorps-Declere A., et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med 2011, 39:1886-1895.
30. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766.
31. Micek S.T., Welch E.C., Khan J., Pervez M., Doherty J.A., Reichley R.M., et al. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. J Hosp Med 2011, 6:405-410.
32. Girometti N., Lewis R.E., Giannella M., Ambretti S., Bartoletti M., Tedeschi S., et al. Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore) 2014, 93:298-309.
33. Marra A.R., de Almeida S.M., Correa L., Silva M., Martino M.D., Silva C.V., et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009, 37:204-209.
34. Ntagiopoulos P.G., Paramythiotou E., Antoniadou A., Giamarellou H., Karabinis A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents 2007, 30:360-365.
35. Furtado G.H., Perdiz L.B., Santana I.L., Camargo M.M., Parreira F.C., Angelieri D.B., et al. Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant Gram-negative bacteria. Am J Infect Control 2008, 36:661-664.
36. Hurford A., Morris A.M., Fisman D.N., Wu J. Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 2012, 4:203-210.
37. Katsios C.M., Burry L., Nelson S., Jivraj T., Lapinsky S.E., Wax R.S., et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care 2012, 16:R216.
38. Ikonomidis I., Makavos G., Nikitas N., Paraskevaidis I., Diamantakis A., Kopterides P., et al. Coronary flow reserve is associated with tissue ischemia and is an additive predictor of intensive care unit mortality to traditional risk scores in septic shock. Int J Cardiol 2014, 172:103-108.
39. Ferrer R., Martin-Loeches I., Phillips G., Osborn T.M., Townsend S., Dellinger R.P., et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014, 42:1749-1755.
40. Kumar A. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence 2014, 5:80-97.